For Immediate Release
Chicago, IL - September 27, 2016 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Intel (NASDAQ: INTC - Free Report ), UnitedHealth (NYSE: UNH - Free Report ), Netflix (NASDAQ: NFLX - Free Report ) ,IBM (NYSE: IBM - Free Report ) and Charles Schwab (NYSE: SCHW - Free Report ).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Monday's Analyst Blog:
New Research Reports for Netflix, Intel, UntiedHealth
Today's Research Daily features new research reports on 16 major stocks, including Intel (NASDAQ: INTC - Free Report ), UnitedHealth (NYSE: UNH - Free Report ) and Netflix (NASDAQ: NFLX - Free Report ). These 16 reports have been hand-picked from the roughly 70 research reports issued by our analyst team today. You can see all of today's research reports here >>>
Shares of Buy rated Intel have been strong performers this year (up nearly 9% year-to-date), but they have lagged other chipmakers. Estimates have started going up lately, reflecting improved outlook for the company's data center business and prospects in the cloud space. Intel has long struggled in the mobile space, but its investments in IoT, security and memory could pay off this year. Intel's non-volatile memory business is poised to take off while it remains the unquestioned leader in the microprocessor market. Additionally, Intel's development program where major architecture and cost constraints are upgraded every alternate year is also encouraging. (You can read the full research report on Intel here>> )
UnitedHealth shares have surged more than 19% year-to-date on continued momentum in the Medicaid and Medicare businesses. The analyst likes continued growth at Optum, with the Optum Rx sub-segment expected to benefit from the Catamaran acquisition. The Zacks analyst explains in today's research report the reasons why estimates are going up, pushing the stock to Zacks Rank #2 (Buy). You can read the full research report on UnitedHealth here>> )
Netflix shares have struggled this year on doubts about subscription growth, stiff competition and the investment incurred on original and acquired content. However, the Zacks analyst remains optimistic about the company's subscriber growth outlook and focus on producing more quality original content. Rapid international expansion is expected to provide a major avenue for growth while applications for both Android and Apple devices have helped it to expand its market share. (You can read the full research report on Netflix here>> )
Today's Long-Term Buys & Sells
Today you can gain access to the best long-term trades unearthed by Zacks Research. These moves have double and triple-digit profit potential and are rarely available to the public. Starting now, you can look inside our stocks under $10, home run and value stock portfolios, plus more. Want a peek at this private information? Click here >>
You can find all of today's stock research reports here>>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today .
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros .
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.